These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 35316296)

  • 1. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
    Arnoletti JP; Reza J; Rosales A; Monreal A; Fanaian N; Whisner S; Srivastava M; Rivera-Otero J; Yu G; Phanstiel Iv O; Altomare DA; Tran Q; Litherland SA
    PLoS One; 2022; 17(3):e0265725. PubMed ID: 35316296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic and bile duct cancer circulating tumor cells (CTC) form immune-resistant multi-cell type clusters in the portal venous circulation.
    Arnoletti JP; Fanaian N; Reza J; Sause R; Almodovar AJ; Srivastava M; Patel S; Veldhuis PP; Griffith E; Shao YP; Zhu X; Litherland SA
    Cancer Biol Ther; 2018; 19(10):887-897. PubMed ID: 30067440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation.
    Arnoletti JP; Zhu X; Almodovar AJ; Veldhuis PP; Sause R; Griffith E; Corpus G; Chang JC; Fanaian N; Litherland SA
    Pancreas; 2017 Jan; 46(1):116-123. PubMed ID: 27400259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
    Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer.
    Takeuchi S; Baghdadi M; Tsuchikawa T; Wada H; Nakamura T; Abe H; Nakanishi S; Usui Y; Higuchi K; Takahashi M; Inoko K; Sato S; Takano H; Shichinohe T; Seino K; Hirano S
    Cancer Res; 2015 Jul; 75(13):2629-40. PubMed ID: 25952647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1.
    He Q; Liu M; Huang W; Chen X; Zhang B; Zhang T; Wang Y; Liu D; Xie M; Ji X; Sun M; Tian D; Xia L
    Hepatology; 2021 Dec; 74(6):3174-3193. PubMed ID: 34288020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
    Zhang A; Qian Y; Ye Z; Chen H; Xie H; Zhou L; Shen Y; Zheng S
    Cancer Med; 2017 Feb; 6(2):463-470. PubMed ID: 28097809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.
    Zhu Y; Knolhoff BL; Meyer MA; Nywening TM; West BL; Luo J; Wang-Gillam A; Goedegebuure SP; Linehan DC; DeNardo DG
    Cancer Res; 2014 Sep; 74(18):5057-69. PubMed ID: 25082815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
    Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH
    Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
    Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
    Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-Type Protein-Tyrosine Phosphatase ζ and Colony Stimulating Factor-1 Receptor in the Intestine: Cellular Expression and Cytokine- and Chemokine Responses by Interleukin-34 and Colony Stimulating Factor-1.
    Zwicker S; Bureik D; Bosma M; Martinez GL; Almer S; Boström EA
    PLoS One; 2016; 11(11):e0167324. PubMed ID: 27898738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterisation of a monoclonal antibody that recognises the chicken CSF1 receptor and confirms that expression is restricted to macrophage-lineage cells.
    Garcia-Morales C; Rothwell L; Moffat L; Garceau V; Balic A; Sang HM; Kaiser P; Hume DA
    Dev Comp Immunol; 2014 Feb; 42(2):278-85. PubMed ID: 24084378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
    Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
    J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery.
    Sergeant G; van Eijsden R; Roskams T; Van Duppen V; Topal B
    BMC Cancer; 2012 Nov; 12():527. PubMed ID: 23157946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic Intra-Aortic Clusters Undergo Myeloid Differentiation Mediated by Mesonephros-Derived CSF1 in Mouse.
    Sasaki T; Tanaka Y; Kulkeaw K; Yumine-Takai A; Tan KS; Nishinakamura R; Ishida J; Fukamizu A; Sugiyama D
    Stem Cell Rev Rep; 2016 Oct; 12(5):530-542. PubMed ID: 27324145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ
    Zuroff LR; Torbati T; Hart NJ; Fuchs DT; Sheyn J; Rentsendorj A; Koronyo Y; Hayden EY; Teplow DB; Black KL; Koronyo-Hamaoui M
    Front Immunol; 2020; 11():1449. PubMed ID: 32765504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.
    Mace TA; Ameen Z; Collins A; Wojcik S; Mair M; Young GS; Fuchs JR; Eubank TD; Frankel WL; Bekaii-Saab T; Bloomston M; Lesinski GB
    Cancer Res; 2013 May; 73(10):3007-18. PubMed ID: 23514705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer.
    Saung MT; Muth S; Ding D; Thomas DL; Blair AB; Tsujikawa T; Coussens L; Jaffee EM; Zheng L
    J Immunother Cancer; 2018 Nov; 6(1):118. PubMed ID: 30424804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.
    Edwards DK; Watanabe-Smith K; Rofelty A; Damnernsawad A; Laderas T; Lamble A; Lind EF; Kaempf A; Mori M; Rosenberg M; d'Almeida A; Long N; Agarwal A; Sweeney DT; Loriaux M; McWeeney SK; Tyner JW
    Blood; 2019 Feb; 133(6):588-599. PubMed ID: 30425048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional evolution of the colony-stimulating factor 1 receptor (CSF1R) and its ligands in birds.
    Hume DA; Gutowska-Ding MW; Garcia-Morales C; Kebede A; Bamidele O; Trujillo AV; Gheyas AA; Smith J
    J Leukoc Biol; 2020 Feb; 107(2):237-250. PubMed ID: 31487076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.